C, A., EC, R., H, C., A, B., L, B., R, M., . . . T, A. (2024). Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction-associated steatotic liver disease. European journal of clinical investigation, 54(11), e14279. https://doi.org/10.1111/eci.14279
Chicago Style (17th ed.) CitationC, Arto, et al. "Metabolic Profiling of Tryptophan Pathways: Implications for Obesity and Metabolic Dysfunction-associated Steatotic Liver Disease." European Journal of Clinical Investigation 54, no. 11 (2024): e14279. https://doi.org/10.1111/eci.14279.
MLA (9th ed.) CitationC, Arto, et al. "Metabolic Profiling of Tryptophan Pathways: Implications for Obesity and Metabolic Dysfunction-associated Steatotic Liver Disease." European Journal of Clinical Investigation, vol. 54, no. 11, 2024, p. e14279, https://doi.org/10.1111/eci.14279.